HLS Therapeutics Inc
TSX:HLS
HLS Therapeutics Inc
Operating Income
HLS Therapeutics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
HLS Therapeutics Inc
TSX:HLS
|
Operating Income
-$11.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
Manitex Capital Inc
XTSX:MNX
|
Operating Income
-CA$965.4k
|
CAGR 3-Years
-41%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
See Also
What is HLS Therapeutics Inc's Operating Income?
Operating Income
-11.8m
USD
Based on the financial report for Dec 31, 2023, HLS Therapeutics Inc's Operating Income amounts to -11.8m USD.
What is HLS Therapeutics Inc's Operating Income growth rate?
Operating Income CAGR 3Y
1%
Over the last year, the Operating Income growth was 13%. The average annual Operating Income growth rates for HLS Therapeutics Inc have been 1% over the past three years .